Altavista Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Gurgaon, Haryana, India, established in 2010.
2010 Gurgaon, Haryana, India Struck Off
Last Updated:
Access Report
About Altavista Pharmaceuticals Private Limited

Altavista Pharmaceuticals Private Limited, a struck off private limited company, was established on 04 February 2010 in Gurgaon, Haryana, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100HR2010PTC040050. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Tikka Gurpartap Singh (Additional Director), Rakesh Baweja (Additional Director), Rajesh Baweja (Director). It is based at House No. 1992, Sector 4, Gurgaon, Haryana, 122001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100HR2010PTC040050

  • Registration Number

    040050

  • Incorporation Date

    04 February 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 1 Month
Company report

Altavista Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Altavista Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Altavista Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Tikka Gurpartap Singh Additional Director 03 May 2010 Current
Rakesh Baweja Additional Director 03 May 2010 Current
Rajesh Baweja Director 07 Apr 2016 Current
Mohan Lal Bairwa Director 04 Feb 2010 Current
Pankaj Verma Director 04 Feb 2010 Current
Vikram Singh Additional Director 03 May 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Altavista Pharmaceuticals.

Enhance accessibility to Altavista Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Altavista Pharmaceuticals revenue growth over time
Altavista Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Altavista Pharmaceuticals?

Unlock access to Altavista Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Altavista Pharmaceuticals?

Unlock and access historical data on people associated with Altavista Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Altavista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altavista Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Altavista Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Rajesh Baweja was appointed as a Director was appointed as a Director on 07 Apr 2016 & has been associated with this company since 9 years 11 months . was completed.

  • Director Appointment

    The activity Tikka Gurpartap Singh was appointed as a Additional Director was appointed as a Additional Director on 03 May 2010 & has been associated with this company since 15 years 10 months . was completed.

  • Director Appointment

    Progress on Rakesh Baweja was appointed as a Additional Director was appointed as a Additional Director on 03 May 2010 & has been associated with this company since 15 years 10 months . was documented.

  • Director Appointment

    Progress on Vikram Singh was appointed as a Additional Director was appointed as a Additional Director on 03 May 2010 & has been associated with this company since 15 years 10 months . was documented.

  • Director Appointment

    Rajesh Baweja was appointed as a Director was appointed as a Director on 04 Feb 2010 & has been associated with this company since 16 years 1 month . was recorded as a recent event.

  • Company Incorporation

    The activity Altavista Pharmaceuticals Private Limited was registered on 04 Feb 2010 with Roc Delhi & aged 16 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Altavista Pharmaceuticals Private Limited?

The CIN of Altavista Pharmaceuticals Private Limited is U24100HR2010PTC040050.

Where is Altavista Pharmaceuticals Private Limited headquartered?

Altavista Pharmaceuticals Private Limited is headquartered at House No. 1992, Sector 4, Gurgaon, Haryana, 122001.

When was Altavista Pharmaceuticals Private Limited incorporated?

Altavista Pharmaceuticals Private Limited was incorporated on 04 February 2010.

Who are the current directors of Altavista Pharmaceuticals Private Limited?

The current directors of Altavista Pharmaceuticals Private Limited are

What is the primary industry of Altavista Pharmaceuticals Private Limited?

The primary industry of Altavista Pharmaceuticals Private Limited is Chemicals.

Is Altavista Pharmaceuticals Private Limited a listed company?

Altavista Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Altavista Pharmaceuticals Private Limited?

The authorized capital of Altavista Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available